Updated ECDC risk assessment on the spread of New Delhi metallo-β-lactamase (NDM) and its variants within Europe
Data currently available from scientific publications and enhanced surveillance in some EU Member States indicate that there is an increase in the spread of all carbapenemase-producing Enterobacteriaceae (CPE) in Europe, including New Delhi metallo-β-lactamase (NDM).
One of the major barriers to our understanding of the magnitude of risk that these highly antibiotic-resistant bacteria represent for Europe is that EU Member States lack systematic surveillance systems and policies to detect NDM infection. Public health preparedness should be enhanced by developing the necessary infrastructure to prevent further spread of all CPE in EU Member States, for example by introducing EU-wide surveillance to improve the monitoring of antibiotic-resistant bacteria.
This report represents a review of medical publications on New Delhi metallo-β-lactamase and its variants within Europe and a summary of the results of a survey sent to the ECDC National Antimicrobial Resistance Focal Points in all EU Member States, Iceland and Norway. The purpose of this survey was to register all cases of NDM colonisation or infection by country and to collect data on patient characteristics and epidemiological histories.
Rapid risk assessment: Dengue outbreak in Réunion, France, and associated risk of autochthonous outbreak in the EU/EEA
18 Jun 2019 - This update of the risk assessment ‘Dengue outbreak in Réunion, France’ published on 5 July 2018, has been triggered by the significant size of the outbreak and its expected duration, which is anticipated to overlap with high vector activity in the southern EU.
Rapid risk assessment: Chlamydia trachomatis false-negative test results by Aptima Combo 2 CT/NG assay (Hologic) in the EU/EEA, 2019
17 Jun 2019 - In April 2019, Finland reported false-negative or equivocal results in patients tested for Chlamydia trachomatis (CT) using Aptima Combo 2 Assay (Hologic) (AC2).
Rapid risk assessment: Regional outbreak of New Delhi metallo-betalactamase-producing carbapenem-resistant Enterobacteriaceae, Italy, 2018–2019
4 Jun 2019 - A large outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacteriaceae (CRE) has been reported from the Tuscany region in Italy. Between November 2018 and May 2019, seven Tuscan hospitals notified a total of 350 cases.